Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen MacMahon

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|November 13, 2015
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysisXinfang Xie, Emily Atkins, Jicheng Lv, et al.
Journal of Hypertension|October 1, 2010
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trialsSébastien Czernichow, Alberto Zanchetti, Fiona Turnbull, et al.
Plos One|March 27, 2019
SMARThealth India: A stepped-wedge, cluster randomised controlled trial of a community health worker managed mobile health intervention for people assessed at high cardiovascular disease risk in rural IndiaDavid Peiris, Devarsetty Praveen, Kishor Mogulluru, et al.
Kidney International|January 11, 2013
Intensive glucose control improves kidney outcomes in patients with type 2 diabetesVlado Perkovic, Hiddo Lambers Heerspink, John Chalmers, et al.
Circulation. Cardiovascular Quality and Outcomes|January 15, 2015
Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trialDavid Peiris, Tim Usherwood, Kathryn Panaretto, et al.
Diabetes Care|May 26, 2021
The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE TrialTu N Nguyen, Katie Harris, Mark Woodward, et al.
Plos One|February 8, 2013
Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trialJun Hata, Hisatomi Arima, Sophia Zoungas, et al.
Diabetes Care|March 24, 2016
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ONMuh Geot Wong, Vlado Perkovic, John Chalmers, et al.
Hypertension (Dallas, Tex. : 1979)|July 14, 2010
Monitoring initial response to Angiotensin-converting enzyme inhibitor-based regimens: an individual patient data meta-analysis from randomized, placebo-controlled trialsKaty J L Bell, Andrew Hayen, Petra Macaskill, et al.
Journal of Hypertension|May 21, 2010
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trialToshiharu Ninomiya, Sophia Zoungas, Bruce Neal, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|November 13, 2015
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysisXinfang Xie, Emily Atkins, Jicheng Lv, et al.
Journal of Hypertension|October 1, 2010
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trialsSébastien Czernichow, Alberto Zanchetti, Fiona Turnbull, et al.
Plos One|March 27, 2019
SMARThealth India: A stepped-wedge, cluster randomised controlled trial of a community health worker managed mobile health intervention for people assessed at high cardiovascular disease risk in rural IndiaDavid Peiris, Devarsetty Praveen, Kishor Mogulluru, et al.
Kidney International|January 11, 2013
Intensive glucose control improves kidney outcomes in patients with type 2 diabetesVlado Perkovic, Hiddo Lambers Heerspink, John Chalmers, et al.
Circulation. Cardiovascular Quality and Outcomes|January 15, 2015
Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trialDavid Peiris, Tim Usherwood, Kathryn Panaretto, et al.
Diabetes Care|May 26, 2021
The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE TrialTu N Nguyen, Katie Harris, Mark Woodward, et al.
Plos One|February 8, 2013
Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trialJun Hata, Hisatomi Arima, Sophia Zoungas, et al.
Diabetes Care|March 24, 2016
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ONMuh Geot Wong, Vlado Perkovic, John Chalmers, et al.
Hypertension (Dallas, Tex. : 1979)|July 14, 2010
Monitoring initial response to Angiotensin-converting enzyme inhibitor-based regimens: an individual patient data meta-analysis from randomized, placebo-controlled trialsKaty J L Bell, Andrew Hayen, Petra Macaskill, et al.
Journal of Hypertension|May 21, 2010
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trialToshiharu Ninomiya, Sophia Zoungas, Bruce Neal, et al.
Pageof 11